Diagnostic Workup for Lip Swelling with Complex Metabolic Derangements
In this 50-year-old woman with lip swelling and severe metabolic derangements including high-anion-gap metabolic acidosis (HAGMA), lactic acidosis, and critical illness, the immediate priority is to address life-threatening metabolic acidosis and sepsis, NOT to pursue angioedema-specific testing at this time.
Critical Context: This is NOT a Simple Angioedema Case
Your patient is critically ill with:
- Severe HAGMA (AG 35) with lactate 9.6 and beta-hydroxybutyrate 5.6
- Septic shock (WBC 31.9,96% neutrophils, requiring vasopressors)
- Severe metabolic acidosis (pH 7.32, HCO3 13-15)
- Progressive anemia (Hgb dropped from 9.8 → 7.0 → 9.4)
- Electrolyte chaos (initial severe hyponatremia 126, hypokalemia 2.3)
The lip swelling is a minor finding in the context of this critical illness and is most likely related to her septic state, fluid shifts, or capillary leak syndrome rather than primary angioedema.
Immediate Diagnostic Priorities (Address Life-Threatening Issues First)
1. Source Control for Sepsis/Infection
- Blood cultures (already pending per your data)
- Imaging for infectious source: CT chest/abdomen/pelvis if not already done
- Wound cultures if any surgical sites or skin breakdown
- The marked leukocytosis (31.9) with extreme left shift (96% neutrophils) indicates overwhelming bacterial infection
2. Causes of HAGMA 1, 2
Your patient has HAGMA with identifiable causes already present:
- Lactic acidosis (lactate 9.6) - likely from septic shock/tissue hypoperfusion
- Ketoacidosis (beta-hydroxybutyrate 5.6) - starvation/stress ketosis
- Possible 5-oxoproline - given the pattern of illness, check if patient received chronic acetaminophen 1
Additional HAGMA testing needed:
- Serum osmolality and osmolal gap - to exclude toxic alcohols 2
- Salicylate level - if not already done
- Urine organic acids - if HAGMA persists unexplained after treating sepsis 1
3. Anemia Workup
- Reticulocyte count - to assess bone marrow response
- Peripheral smear review (already shows microcytosis, hypochromia, elliptocytes)
- Hemolysis labs: LDH, haptoglobin, indirect bilirubin
- Iron studies (already show severe iron deficiency: iron 16, transferrin sat 4%)
- GI evaluation for occult bleeding source once stabilized
4. Severe Vitamin D Deficiency
- Vitamin D <6 is critically low and may contribute to hypocalcemia and metabolic issues
- Requires aggressive repletion
Angioedema Evaluation: ONLY After Stabilization
The lip swelling should NOT be worked up as primary angioedema during acute critical illness. However, if this represents recurrent angioedema episodes (not clear from your presentation), the following algorithmic approach applies once the patient is stable 3:
Step 1: Exclude Medication-Associated Angioedema 3, 4
- Review ALL medications for:
- ACE inhibitors
- ARBs
- DPP-4 inhibitors
- NSAIDs
- Tissue plasminogen activators
Step 2: Screen for C1-Inhibitor Deficiency 4
Only if recurrent angioedema without urticaria:
- Complement C4 level - screening test (95% sensitive for C1-INH deficiency) 4
- C1-INH antigen level
- C1-INH functional level (chromogenic assay preferred) 4
- C1q level - if acquired C1-INH deficiency suspected 4
Interpretation:
- If C4 normal → C1-INH deficiency essentially excluded 4
- If C4 low + C1-INH low → Type I HAE
- If C4 low + C1-INH normal antigen but low function → Type II HAE 4
- If C4 low + C1q low → Acquired C1-INH deficiency 4
Step 3: If C1-INH Testing Normal, Consider HAE with Normal C1-INH 3
Diagnostic algorithm per 2025 consensus 3:
Family history assessment - critical for HAE-nC1INH diagnosis
Genetic testing if strong family history:
- Targeted gene sequencing for known HAE-nC1INH genes (F12, PLG, ANGPT1, KNG1, MYOF, HS3ST6)
- HAE-FXII most common, predominantly affects women, estrogen-triggered 3
Trial of mast cell-targeted therapy if no family history:
- High-dose H1 antihistamines (up to 4× standard dose)
- Add montelukast
- Consider omalizumab
- If no response → suggests bradykinin-mediated angioedema 3
Trial of bradykinin B2 receptor antagonist - diagnostic and therapeutic 3
Common Pitfalls to Avoid
- Do NOT pursue angioedema workup during acute critical illness - the lip swelling is likely secondary to sepsis/capillary leak
- Do NOT assume isolated angioedema when patient has multisystem organ failure
- Do NOT delay sepsis treatment to pursue angioedema testing
- Do NOT use antihistamines, corticosteroids, or epinephrine if this were true HAE (they are ineffective) 3, 4
- Do NOT forget that C4 must be sent promptly to lab (degrades with delay) 4
Clinical Decision Algorithm
Is the patient critically ill with sepsis/HAGMA?
- YES → Treat sepsis, HAGMA, and metabolic derangements FIRST. Defer angioedema workup.
- NO → Proceed with angioedema evaluation
If pursuing angioedema workup, is patient on ACE-I/ARB?
Is C4 low?
- YES → Check C1-INH antigen, function, and C1q 4
- NO → Consider HAE-nC1INH if recurrent episodes without urticaria 3
Is there strong family history of angioedema?
- YES → Genetic testing for HAE-nC1INH 3
- NO → Trial mast cell-targeted therapy, then bradykinin antagonist if no response 3
Bottom Line for THIS Patient
Address the critical illness first: sepsis source control, treat HAGMA/lactic acidosis, correct electrolytes, transfuse for severe anemia, and replicate vitamin D. The lip swelling is almost certainly a manifestation of critical illness (sepsis-related capillary leak, fluid shifts) rather than primary angioedema. Only pursue formal angioedema evaluation if episodes recur after recovery from acute illness.